Related references
Note: Only part of the references are listed.TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
Jamilah Abusarah et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia
Feng-Ting Dao et al.
SCIENTIFIC REPORTS (2021)
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties
Abed El-Hakim El-Kadiry et al.
FRONTIERS IN PHARMACOLOGY (2020)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Haoyu Zhan et al.
NATURE GENETICS (2020)
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts
Sara R. Rashkin et al.
NATURE COMMUNICATIONS (2020)
The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
Valerio Gristina et al.
PHARMACEUTICALS (2020)
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
Brett M. Stevens et al.
NATURE CANCER (2020)
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Peter van Galen et al.
CELL (2019)
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute
Binbin Wang et al.
NATURE PROTOCOLS (2019)
Applications of machine learning in drug discovery and development
Jessica Vamathevan et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Irene Baccelli et al.
CANCER CELL (2019)
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Matthew B. Dong et al.
CELL (2019)
Identifying chemogenetic interactions from CRISPR screens with drugZ
Medina Colic et al.
GENOME MEDICINE (2019)
Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning
Daqi Wang et al.
NATURE COMMUNICATIONS (2019)
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing
Jinyan Chan et al.
BIOINFORMATICS (2019)
PubChem 2019 update: improved access to chemical data
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2019)
Chemogenetic interactions in human cancer cells
Medina Colic et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data
Amar Koleti et al.
NUCLEIC ACIDS RESEARCH (2018)
A novel computational approach for drug repurposing using systems biology
Azam Peyvandipour et al.
BIOINFORMATICS (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening
Shurong Hou et al.
SLAS DISCOVERY (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Matthew H. Bailey et al.
CELL (2018)
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Michal Zimmermann et al.
NATURE (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Predicting protein targets for drug-like compounds using transcriptomics
Nicolas A. Pabon et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Cas-analyzer: an online tool for assessing genome editing results using NGS data
Jeongbin Park et al.
BIOINFORMATICS (2017)
Demystifying HDL Cholesterol A Human Knockout to the Rescue?
Amit V. Khera et al.
CLINICAL CHEMISTRY (2017)
Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells
Judith F. Ashouri et al.
JOURNAL OF IMMUNOLOGY (2017)
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
Bin Chen et al.
GASTROENTEROLOGY (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing
Nehme El-Hachem et al.
PHARMACOGENOMICS (2017)
Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
Bin Chen et al.
NATURE COMMUNICATIONS (2017)
PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens
Philipp N. Spahn et al.
SCIENTIFIC REPORTS (2017)
Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
Traver Hart et al.
G3-GENES GENOMES GENETICS (2017)
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Ahmed Fouda et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220
Panpan Hou et al.
CANCER RESEARCH (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
10 Years of GWAS Discovery: Biology, Function, and Translation
Peter M. Visscher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
Nehme El-Hachem et al.
CANCER RESEARCH (2017)
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Tim Wang et al.
CELL (2017)
BAGEL: a computational framework for identifying essential genes from pooled library screens
Traver Hart et al.
BMC BIOINFORMATICS (2016)
Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia
David B. Sykes et al.
CELL (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Leveraging Big Data to Transform Target Selection and Drug Discovery
B. Chen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions
Diana M. Munoz et al.
CANCER DISCOVERY (2016)
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Andrew J. Aguirre et al.
CANCER DISCOVERY (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert et al.
NATURE (2015)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Developing predictive assays: The phenotypic screening rule of 3
Fabien Vincent et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
Relating Chemical Structure to Cellular Response: An Integrative Analysis of Gene Expression, Bioactivity, and Structural Data Across 11,000 Compounds
B. Chen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis
J. Bertacchini et al.
LEUKEMIA (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Phenotypic screening in cancer drug discovery - past, present and future
John G. Moffat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi et al.
CELL (2013)
Phenotypic screens as a renewed approach for drug discovery
Wei Zheng et al.
DRUG DISCOVERY TODAY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou et al.
NATURE GENETICS (2013)
CRISPR RNA-guided activation of endogenous human genes
Morgan L. Maeder et al.
NATURE METHODS (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Pharmacogenomics and Patient Care: One Size Does Not Fit All
K. M. Giacomini et al.
Science Translational Medicine (2012)
Chapter 7: Pharmacogenomics
Konrad J. Karczewski et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
High-Throughput Giardia lamblia Viability Assay Using Bioluminescent ATP Content Measurements
Catherine Z. Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance
Johannes Zuber et al.
GENES & DEVELOPMENT (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Impact of high-throughput screening in biomedical research
Ricardo Macarron et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A Useful Approach to Identify Novel Small-Molecule Inhibitors of Wnt-Dependent Transcription
Kenneth Ewan et al.
CANCER RESEARCH (2010)
Applications of High Content Screening in Life Science Research
Joseph M. Zock
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
Haley Hieronymus et al.
CANCER CELL (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Therapeutic targets: Progress of their exploration and investigation of their characteristics
C. J. Zheng et al.
PHARMACOLOGICAL REVIEWS (2006)
Share Paper
